Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126672261 | 12667226 | 1 | I | 20160805 | 20160819 | 20160819 | EXP | US-CIPLA LTD.-2016US17326 | CIPLA | BUTANI L, DUCORE J. END-STAGE RENAL DISEASE FROM CAST NEPHROPATHY IN A TEENAGER WITH NEUROENDOCRINE CARCINOMA. JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY. 2016;38 (5):E177 TO E179 | 0.00 | Y | 0.00000 | 20160819 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126672261 | 12667226 | 1 | PS | Irinotecan | IRINOTECAN | 1 | Unknown | UNK | U | U | 77219 | ||||||||
126672261 | 12667226 | 2 | SS | Irinotecan | IRINOTECAN | 1 | Unknown | UNK, SECOND CYCLE | U | U | 77219 | ||||||||
126672261 | 12667226 | 3 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
126672261 | 12667226 | 4 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | UNK, SECOND CYCLE | U | U | 0 | ||||||||
126672261 | 12667226 | 5 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
126672261 | 12667226 | 6 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | UNK | U | U | 0 | ||||||||
126672261 | 12667226 | 7 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
126672261 | 12667226 | 8 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
126672261 | 12667226 | 9 | SS | VINORELBINE | VINORELBINEVINORELBINE TARTRATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
126672261 | 12667226 | 10 | SS | SULFAMETHOXAZOLE-TRIMETHOPRIM (SMZ) | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK, 3 TIMES A WEEK | U | 0 | |||||||||
126672261 | 12667226 | 11 | SS | Penicillin | PENICILLIN | 1 | Unknown | UNK, QD | U | 0 | QD | ||||||||
126672261 | 12667226 | 12 | SS | QIZHEN | HERBALS | 1 | Unknown | UNK | U | 0 | |||||||||
126672261 | 12667226 | 13 | C | Acetaminophen-hydrocodone | 2 | Unknown | UNK | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126672261 | 12667226 | 1 | Neuroendocrine carcinoma metastatic |
126672261 | 12667226 | 3 | Neuroendocrine carcinoma metastatic |
126672261 | 12667226 | 5 | Neuroendocrine carcinoma metastatic |
126672261 | 12667226 | 6 | Neuroendocrine carcinoma metastatic |
126672261 | 12667226 | 7 | Neuroendocrine carcinoma metastatic |
126672261 | 12667226 | 8 | Neuroendocrine carcinoma metastatic |
126672261 | 12667226 | 9 | Neuroendocrine carcinoma metastatic |
126672261 | 12667226 | 10 | Prophylaxis |
126672261 | 12667226 | 11 | Prophylaxis |
126672261 | 12667226 | 13 | Abdominal discomfort |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126672261 | 12667226 | OT |
126672261 | 12667226 | DE |
126672261 | 12667226 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126672261 | 12667226 | Abdominal distension | |
126672261 | 12667226 | Constipation | |
126672261 | 12667226 | Death | |
126672261 | 12667226 | Disease progression | |
126672261 | 12667226 | End stage renal disease | |
126672261 | 12667226 | Haemodialysis | |
126672261 | 12667226 | Hypersplenism | |
126672261 | 12667226 | Myeloma cast nephropathy | |
126672261 | 12667226 | Renal tubular necrosis | |
126672261 | 12667226 | Thrombocytopenia | |
126672261 | 12667226 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |